Eclipx Group Ltd delivers great profit result: Time to invest?

Eclipx Group Ltd (ASX:ECX) shares are higher after a solid full year result and strong forward guidance. Is it time you invested?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This morning leading fleet and equipment leasing company Eclipx Group Ltd (ASX: ECX) announced a strong full year result, culminating in a 14% jump in cash net profit after tax and amortisation (NPATA) to $55.3 million or 22 cents per share.

On a normal day its shares might have rocketed higher, especially with the bullish guidance management provided. But with the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) deep in negative territory today, its shares have climbed just 1% higher to $3.83 at lunch.

Driving the growth was the impressive increase in the number of vehicles under management or financed. At the end of FY 2016 Eclipx managed or financed a total of 99,254 vehicles across Australia and New Zealand, up a whopping 24% on last year.

Thanks to a 15% increase in new business writings in FY 2016, management believes it has a strong pipeline of future revenue. So much so it is confident enough to provide cash NPATA guidance of $65.5 million to $67 million in FY 2017.

This equates to year-on-year growth of 18% to 21%. If it grows earnings per share by the same rate then I would expect to see EPS in FY 2017 of approximately 26 cents to 26.6 cents.

If the company delivers in the middle of its guidance range then it would mean its shares are changing hands at just 14.5x FY 2017's earnings today.

Considering the strong growth prospects it has, I think the current share price represents great value for investors.

There is of course a lot of choice for investors in the industry with the likes of Smartgroup Corporation Ltd (ASX: SIQ) and SG Fleet Group Ltd (ASX: SGF) to name just two, but Eclipx would be up there as one of the best options in my opinion.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »